These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16419382)

  • 1. State of the art coronary heart disease risk estimations based on the Framingham heart study.
    Reissigová J; Tomecková M
    Cent Eur J Public Health; 2005 Dec; 13(4):180-6. PubMed ID: 16419382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting coronary heart disease risk using the Framingham and PROCAM equations in dyslipidaemic patients without overt vascular disease.
    Vrentzos GE; Papadakis JA; Ganotakis ES; Paraskevas KI; Gazi IF; Tzanakis N; Nair DR; Mikhailidis DP
    Int J Clin Pract; 2007 Oct; 61(10):1643-53. PubMed ID: 17877651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
    Metcalf PA; Wells S; Scragg RK; Jackson R
    N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ten-year risk prediction in French men using the Framingham coronary score: results from the national SU.VI.MAX cohort.
    Vergnaud AC; Bertrais S; Galan P; Hercberg S; Czernichow S
    Prev Med; 2008 Jul; 47(1):61-5. PubMed ID: 18456313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiencies of cardiovascular risk prediction models for type 1 diabetes.
    Zgibor JC; Piatt GA; Ruppert K; Orchard TJ; Roberts MS
    Diabetes Care; 2006 Aug; 29(8):1860-5. PubMed ID: 16873793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Framingham Coronary Heart Disease Risk Score in dementia caregivers relative to non-caregiving controls.
    von Känel R; Mausbach BT; Patterson TL; Dimsdale JE; Aschbacher K; Mills PJ; Ziegler MG; Ancoli-Israel S; Grant I
    Gerontology; 2008; 54(3):131-7. PubMed ID: 18204247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a global risk educational tool on primary coronary prevention: the Atherosclerosis Assessment Via Total Risk (AVIATOR) study.
    Jacobson TA; Gutkin SW; Harper CR
    Curr Med Res Opin; 2006 Jun; 22(6):1065-73. PubMed ID: 16846539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiovascular risk factors. Insights from Framingham Heart Study].
    O'Donnell CJ; Elosua R
    Rev Esp Cardiol; 2008 Mar; 61(3):299-310. PubMed ID: 18361904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary risk factors and myocardial perfusion in asymptomatic adults: the Multi-Ethnic Study of Atherosclerosis (MESA).
    Wang L; Jerosch-Herold M; Jacobs DR; Shahar E; Folsom AR
    J Am Coll Cardiol; 2006 Feb; 47(3):565-72. PubMed ID: 16458137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presentation of multivariate data for clinical use: The Framingham Study risk score functions.
    Sullivan LM; Massaro JM; D'Agostino RB
    Stat Med; 2004 May; 23(10):1631-60. PubMed ID: 15122742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the 1997 and 2003 American Diabetes Association classification of impaired fasting glucose: impact on prevalence of impaired fasting glucose, coronary heart disease risk factors, and coronary heart disease in a community-based medical practice.
    Kim SH; Chunawala L; Linde R; Reaven GM
    J Am Coll Cardiol; 2006 Jul; 48(2):293-7. PubMed ID: 16843178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of cardiovascular risk: a comparison between the Framingham and the SCORE model in people under 60 years of age.
    Scheltens T; Verschuren WM; Boshuizen HC; Hoes AW; Zuithoff NP; Bots ML; Grobbee DE
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):562-6. PubMed ID: 18756178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relation between non-alcoholic fatty liver disease and the risk of coronary heart disease in Koreans.
    Choi SY; Kim D; Kim HJ; Kang JH; Chung SJ; Park MJ; Kim YS; Kim CH; Choi SH; Kim W; Kim YJ; Yoon JH; Lee HS; Cho SH; Sung MW; Oh BH
    Am J Gastroenterol; 2009 Aug; 104(8):1953-60. PubMed ID: 19491838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E; Zyriax BC; Eidenmüller B; Boeing H
    Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shrinking cardiovascular risk through bariatric surgery: application of Framingham risk score in gastric bypass.
    Kligman MD; Dexter DJ; Omer S; Park AE
    Surgery; 2008 Apr; 143(4):533-8. PubMed ID: 18374051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Family history of premature coronary heart disease and coronary artery calcification: Multi-Ethnic Study of Atherosclerosis (MESA).
    Nasir K; Budoff MJ; Wong ND; Scheuner M; Herrington D; Arnett DK; Szklo M; Greenland P; Blumenthal RS
    Circulation; 2007 Aug; 116(6):619-26. PubMed ID: 17646582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of coronary heart disease in a population with high prevalence of diabetes and albuminuria: the Strong Heart Study.
    Lee ET; Howard BV; Wang W; Welty TK; Galloway JM; Best LG; Fabsitz RR; Zhang Y; Yeh J; Devereux RB
    Circulation; 2006 Jun; 113(25):2897-905. PubMed ID: 16769914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Favorable cardiovascular risk profile and 10-year coronary heart disease incidence in women and men: results from the Progetto CUORE.
    Palmieri L; Donfrancesco C; Giampaoli S; Trojani M; Panico S; Vanuzzo D; Pilotto L; Cesana G; Ferrario M; Chiodini P; Sega R; Stamler J
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):562-70. PubMed ID: 16874146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adding socioeconomic status to Framingham scoring to reduce disparities in coronary risk assessment.
    Fiscella K; Tancredi D; Franks P
    Am Heart J; 2009 Jun; 157(6):988-94. PubMed ID: 19464408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.